EUVIMEDEUVIMED entdecken
Open Access

Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study

Brandon J Coombes, Vincent Millischer, Anthony Batzler, Beth Larrabee, Liping Hou, Sergi Papiol, Urs Heilbronner, Mazda Adli, Kazufumi Akiyama, Nirmala Akula, Azmeraw T Amare, Raffaella Ardau und 48 weitere

Complex Psychiatry · 2021 · 7 (3-4) · 80-89

DOI: 10.1159/000519707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Complex Psychiatry, online erschienen am 18.11.2021. Verfasst von Brandon J Coombes und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Response to lithium varies widely between individuals with bipolar disorder (BD). Polygenic risk scores (PRSs) can uncover pharmacogenomics effects and may help predict drug response. Patients (N = 2,510) with BD were assessed for long-term lithium response in the Consortium on Lithium Genetics using the Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder score. PRSs for attention-deficit/hyperactivity disorder (ADHD), major depressive disorder (MDD), and schizophrenia (SCZ) were computed using lassosum and in a model including all three PRSs and other covariates, and the PRS of ADHD (β = −0.14; 95% confidence interval [CI]: −0.24 to −0.03; p value = 0.010) and MDD (β = −0.16; 95% CI: −0.27 to −0.04; p value = 0.005) predicted worse quantitative lithium response. A higher SCZ PRS was associated with higher rates of medication nonadherence (OR = 1.61; 95% CI: 1.34–1.93; p value = 2e−7). This study indicates that genetic risk for ADHD and depression may influence lithium treatment response. Interestingly, a higher SCZ PRS was associated with poor adherence, which can negatively impact treatment response. Incorporating genetic risk of ADHD, depression, and SCZ in combination with clinical risk may lead to better clinical care for patients with BD.

Schlagwörter

Stichwörter der Autor:innen

AdherenceAttention-deficit/hyperactivity disorderBipolar disorderLithium responsePolygenic risk scores

Autor:innen und Institutionen

  • Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
  • Department for Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, Maryland, USA.
  • Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, Munich, Germany.
  • Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Munich, Germany.

Zitieren

APA

Coombes, B. J., Millischer, V., Batzler, A., Larrabee, B., Hou, L., Papiol, S., Heilbronner, U., Adli, M., Akiyama, K., Akula, N., Amare, A. T., Ardau, R., Arias, B., Aubry, J. M., Backlund, L., Bauer, M., Baune, B. T., Bellivier, F., Benabarre, A., …, & Lavebratt, C. (2021). Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study. Complex Psychiatry, 7(3-4), 80-89. https://doi.org/10.1159/000519707

Vancouver

Coombes BJ, Millischer V, Batzler A, Larrabee B, Hou L, Papiol S, et al. Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study. Complex Psychiatry. 2021;7(3-4):80-89. doi:10.1159/000519707

BibTeX
@article{Coombes2021,
  author = {Coombes, Brandon J and Millischer, Vincent and Batzler, Anthony and Larrabee, Beth and Hou, Liping and Papiol, Sergi and Heilbronner, Urs and Adli, Mazda and Akiyama, Kazufumi and Akula, Nirmala and Amare, Azmeraw T and Ardau, Raffaella and Arias, Barbara and Aubry, Jean-Michel and Backlund, Lena and Bauer, Michael and Baune, Bernhard T and Bellivier, Frank and Benabarre, Antoni and Bengesser, Susanne and Bhattacharjee, Abesh Kumar and Cervantes, Pablo and Chen, Hsi-Chung and Chillotti, Caterina and Cichon, Sven and Clark, Scott R and Colom, Francesc and Cruceanu, Cristiana and Czerski, Piotr M and Dalkner, Nina and Degenhardt, Franziska and Del Zompo, Maria and DePaulo, J Raymond and Étain, Bruno and Falkai, Peter and Ferensztajn-Rochowiak, Ewa and Forstner, Andreas J and Frisen, Louise and Gard, Sébastien and Garnham, Julie S and Goes, Fernando S and Grigoroiu-Serbanescu, Maria and Grof, Paul and Hashimoto, Ryota and Hauser, Joanna and Herms, Stefan and Hoffmann, Per and Jamain, Stephane and Jiménez, Esther and Kahn, Jean-Pierre and Kassem, Layla and Kato, Tadafumi and Kelsoe, John R and Kittel-Schneider, Sarah and König, Barbara and Kuo, Po-Hsiu and Kusumi, Ichiro and Laje, Gonzalo and Landén, Mikael and Lavebratt, Catharina},
  title = {Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study},
  journal = {Complex Psychiatry},
  year = {2021},
  volume = {7},
  number = {3-4},
  pages = {80--89},
  doi = {10.1159/000519707}
}
Kostenlos starten →